Trial Profile
Phase IV double-blind randomized study to evaluate safety and efficacy of interferon beta-1a (Avonex) plus simvastatin (Zocor) combination therapy in clinically isolated syndrome suggestive of multiple sclerosis over a one year period
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 20 Nov 2005 New trial record.